Qiagen N.V. (LON: 0RLT)
London
· Delayed Price · Currency is GBP · Price in EUR
43.54
-1.85 (-4.08%)
At close: Jan 22, 2025
Qiagen Revenue
Qiagen had revenue of $501.87M USD in the quarter ending September 30, 2024, with 5.46% growth. This brings the company's revenue in the last twelve months to $1.97B, up 0.62% year-over-year. In the year 2023, Qiagen had annual revenue of $1.97B, down -8.23%.
Revenue (ttm)
$1.97B
Revenue Growth
+0.62%
P/S Ratio
n/a
Revenue / Employee
$355.48K
Employees
5,531
Market Cap
8.53B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | 1.53B | 24.58M | 1.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 221.41B |
AstraZeneca | 38.20B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |
Qiagen News
- 10 days ago - Qiage announces $300M buyback plan - Seeking Alpha
- 10 days ago - Qiagen NV Announces $300 Million Synthetic Share Repurchase Plan - GuruFocus
- 10 days ago - QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase - Business Wire
- 13 days ago - Qiagen NV (QGEN) Enhances QIAcuity Digital PCR System with Advanced Multiplexing Capabilities - GuruFocus
- 13 days ago - QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples - Business Wire
- 13 days ago - QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care - Business Wire
- 15 days ago - QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content - Business Wire
- 5 weeks ago - EY wins first Dax audit client since Wirecard scandal - Financial Times